Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCU3J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,020
Award facts
- Contract value 100% obligated
- $28,020.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $28,020.49 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen auto-injectors on a firm fixed-price basis. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical.
AmerisourceBergen Drug Corp holds a significant $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide. This prime vendor contract enables the company to deliver a broad range of pharmaceutical products and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Cosentyx order fulfills critical medical supply needs, as the company has demonstrated consistent capability to meet federal procurement requirements through open competition across numerous delivery orders involving both brand-name specialty medications and generic drugs.
Quick answers
Who was awarded contract SPE2DR26FCU3J?
SPE2DR26FCU3J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FCU3J worth?
The government has obligated $28,020 on SPE2DR26FCU3J.
Is contract SPE2DR26FCU3J an order under another contract?
Yes. SPE2DR26FCU3J is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCU3J competed?
The extent of competition for SPE2DR26FCU3J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award